Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Volume 2, Issue 3 (2016)

Editorial

Pages: 1 - 2

Anticancer Molecules in Brain: Implication for Novel Strategy for Cancer Immunotherapy

Run Xiao,Stephen M Bergin, Manchao Zhang and Lei Cao

DOI: 10.4172/2471-9552.1000e104

Share this article

Commentary

Pages: 1 - 3

The Society of Hematologic Oncology (SOHO): Continuing to Move Forward in the Battle against Hematologic Malignancies

Hagop Kantarjian

DOI: 10.4172/2471-9552.1000121

Share this article

Short Communication

Pages: 1 - 4

Budesonide Suppresses Pulmonary Antibacterial Host Defense by Down-Regulating Cathelicidin-Related Antimicrobial Peptide

Xi Dai and Guoping Li

DOI: 10.4172/2471-9552.1000122

Share this article

Commentary

Pages: 1 - 2

Bispecific Antibody Goes to Hybrid

Aifen Li, Li Li, Qing Li and Zhong Wang

DOI: 10.4172/2471-9552.1000123

Share this article

Commentary

Pages: 1 - 4

Immunogenic Chemotherapy Using Cyclophosphamide and Gemcitabine

Mamoru Harada

DOI: 10.4172/2471-9552.1000124

Share this article

Commentary

Pages: 1 - 3

The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine

Alicia Lenzen, Lijie Zhai, Kristen L Lauing, Galina Gritsina, Erik Ladomersky, Matthew Genet, C David James, Orin Bloch, and Derek A Wainwright

DOI: 10.4172/2471-9552.1000125

Share this article

Research Article

Pages: 1 - 6

Risk of Musculoskeletal Complications in Cancer Patients Treated with Nivolumab

Xiangyi Kong, Xiaobo Zhang and Yanguo Kong

DOI: 10.4172/2471-9552.1000126

Share this article
Top